IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1 studied for growth signaling. It is researched most often for Growth signaling, Cell proliferation and Body composition. Primarily a research reagent; limited human safety data. This guide walks through what IGF-1 LR3 is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is IGF-1 LR3?
IGF-1 LR3 is a modified, longer-acting version of insulin-like growth factor 1. Its extended half-life and reduced binding-protein affinity make it a research tool for studying IGF-1 signaling, growth and cell proliferation.
Also known as: Long R3 IGF-1.
How does IGF-1 LR3 work?
IGF-1 LR3 is a modified, longer-acting version of insulin-like growth factor 1. Changes to its structure extend its half-life and reduce binding to carrier proteins, making it a research tool for studying IGF-1 signaling, growth, and cell proliferation.
What is IGF-1 LR3 researched for?
In the research and community discussion, IGF-1 LR3 comes up most often in connection with Growth signaling, Cell proliferation and Body composition. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Growth signaling
- Cell proliferation
- Body composition
What does the research actually show?
Primarily a research reagent; limited human safety data. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting IGF-1 LR3 as a guaranteed treatment is getting ahead of the evidence.
Safety and considerations
Affects blood sugar and cell growth pathways; potential risks around proliferation. Not an approved therapy. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about IGF-1 LR3
To go deeper, see the IGF-1 LR3 library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where IGF-1 LR3 might fit your goals.
Frequently asked questions
IGF-1 signaling, cell proliferation, and body composition — largely as a research reagent.
The "Long R3" modifications extend its duration of action and reduce binding-protein affinity compared with native IGF-1.
It affects blood sugar and cell-growth pathways, with potential proliferation-related risks. It is not an approved therapy and human safety data is limited.
Not sure if IGF-1 LR3 fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.